MACULARIS Trademark

Trademark Overview

On Tuesday, November 26, 2013, a trademark application was filed for MACULARIS with the United States Patent and Trademark Office. The USPTO has given the MACULARIS trademark a serial number of 79141329. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, November 26, 2023. This trademark is owned by JLS Property Pty Ltd. The MACULARIS trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

monoclonal antibodies for therapeutic purposes, namely, monoclonal antibodies for treatment of macular degeneration or for treatment, maintaining and protecting health of the macular region; medical therapeutic agents for treatment of macular degeneration, namely, medical therapeutic agents for treatment, maintaining and protecting health of the macular region; medical therapeutic drugs for treatment of macular degeneration, namely, drugs directed against complement cascade factors and proteins, anti-inflammatories, anti-oxidants, lutein, xanthine and xanthine derivatives

Medical services, namely, ophthalmology; optometry
macularis

General Information

Serial Number79141329
Word MarkMACULARIS
Filing DateTuesday, November 26, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, November 26, 2023
Registration Number4787775
Registration DateTuesday, August 11, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 26, 2015

Trademark Statements

Goods and Servicesmonoclonal antibodies for therapeutic purposes, namely, monoclonal antibodies for treatment of macular degeneration or for treatment, maintaining and protecting health of the macular region; medical therapeutic agents for treatment of macular degeneration, namely, medical therapeutic agents for treatment, maintaining and protecting health of the macular region; medical therapeutic drugs for treatment of macular degeneration, namely, drugs directed against complement cascade factors and proteins, anti-inflammatories, anti-oxidants, lutein, xanthine and xanthine derivatives
Goods and ServicesMedical services, namely, ophthalmology; optometry

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 25, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJLS Property Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAU
Party NameJLS Property Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAU
Party NameJLS Property Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAU

Trademark Events

Event DateEvent Description
Friday, January 17, 2014APPLICATION FILING RECEIPT MAILED
Saturday, March 15, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 17, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 17, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 10, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, January 13, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 12, 2014ASSIGNED TO EXAMINER
Friday, March 14, 2014NON-FINAL ACTION WRITTEN
Monday, March 17, 2014REFUSAL PROCESSED BY MPU
Friday, April 4, 2014REFUSAL PROCESSED BY IB
Wednesday, April 1, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 17, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 17, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 23, 2014FINAL REFUSAL WRITTEN
Wednesday, September 24, 2014FINAL REFUSAL MAILED
Monday, March 23, 2015TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 23, 2015TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 23, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 23, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 30, 2015ASSIGNED TO LIE
Wednesday, April 1, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 10, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, April 20, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 20, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 6, 2015NOTICE OF PUBLICATION
Wednesday, May 6, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 6, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, May 22, 2015NOTIFICATION PROCESSED BY IB
Tuesday, May 26, 2015PUBLISHED FOR OPPOSITION
Wednesday, June 10, 2015NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, June 26, 2015NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, August 11, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, November 11, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, January 20, 2016FINAL DISPOSITION PROCESSED
Wednesday, January 20, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 5, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 25, 2022CANCELLED SECTION 71
Saturday, November 26, 2022INVALIDATION PROCESSED
Tuesday, October 25, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, November 26, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, November 3, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, June 17, 2024DEATH OF INTERNATIONAL REGISTRATION
Tuesday, December 27, 2022TOTAL INVALIDATION PROCESSED BY THE IB

Related Keywords

macularis macular treatment therapeutic namely medical degeneration agents monoclonal xanthine anti